trial · primary record
Adavosertib
Advanced Lymphoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 33 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT04439227 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:37.867Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04439227
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.